Versant Capital Management’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $121K | Buy |
1,137
+79
| +7% | +$8.38K | 0.02% | 610 |
|
|
2025
Q1 | $131K | Buy |
1,058
+91
| +9% | +$11.3K | 0.02% | 542 |
|
|
2024
Q4 | $119K | Buy |
967
+350
| +57% | +$43.1K | 0.03% | 263 |
|
|
2024
Q3 | $68.7K | Buy |
617
+346
| +128% | +$38.5K | 0.02% | 344 |
|
|
2024
Q2 | $28.9K | Buy |
271
+269
| +13,450% | +$28.7K | 0.01% | 580 |
|
|
2024
Q1 | $241 | Hold |
2
| – | – | ﹤0.01% | 1815 |
|
|
2023
Q4 | $246 | Sell |
2
-3
| -60% | -$369 | ﹤0.01% | 1843 |
|
|
2023
Q3 | $647 | Hold |
5
| – | – | ﹤0.01% | 1648 |
|
|
2023
Q2 | $620 | Buy |
5
+3
| +150% | +$372 | ﹤0.01% | 1766 |
|
|
2023
Q1 | $290 | Hold |
2
| – | – | ﹤0.01% | 1665 |
|
|
2022
Q4 | $319 | Hold |
2
| – | – | ﹤0.01% | 1515 |
|
|
2022
Q3 | $0 | Buy |
+2
| New | – | ﹤0.01% | 1533 |
|
|
2020
Q2 | – | Sell |
-3
| Closed | – | – | 1426 |
|
|
2020
Q1 | $0 | Buy |
+3
| New | – | ﹤0.01% | 1489 |
|